FindTrial
Sign In

Rolul miRNA in modelarea imuna dupa splenectomia totala si partiala.

Role of miRNA in immune modulation after total or partial splenectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026182
Enrollment
Unknown
Registered
2019-09-25
Start date
2013-01-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological disorders of the spleen

Interventions

Total:Total Splenectomy
Subtotal:Subtotal Splenectomy

Sponsors

UEFISCDI
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 53 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe anemia and recurrent blood transfusions that required splenectomy.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Hemoglobin Level;Reticulocytes;—

Countries

Romania

Contacts

Public ContactCatalin Vasilescu

Fundeni Clinical Institute

catvasilescu@gmail.com+40 7 21207260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026